PLoS BiologyEvolutionary BiologyPeer-reviewed journal article
Viral disease outcomes are indistinguishable between experimentally infected bats and rodents
Maxwell J. FarrelliD, Samantha K. TuckeriD, Nardus MollentzeiD, Daniel G. StreickeriD
Abstract
A common explanation for bats being a conspicuous source of zoonotic viruses is their purported ability to coexist with viruses without suffering overt disease. This belief has catalyzed the discovery of unique features of bat immune systems which may have translational value as broad-spectrum antivirals, particularly if they evolved as a byproduct of bats' unique life history rather than through conventional co-evolutionary processes. Surprisingly, whether bats compared to other host groups suffer less disease from co-evolved viruses or from viruses generally has not been formally assessed. Here, synthesizing eighty-six years of experimental infections, involving 54 viruses, 85 host species, and over 5,600 animals, we document disease in bats following inoculation by taxonomically diverse viruses, including ones that are relatively benign in humans. The occurrence of overt disease, the likelihood of mortality, and the severity of disease in bats were indistinguishable from those experienced by rodents, another group associated with many zoonotic viruses. These patterns were consistent when considering only bat-associated viruses inoculated into bats and rodent-associated viruses inoculated into rodents and among inoculations which lacked shared co-evolutionary history. Instead, disease outcomes following infection were shaped by experimental design, viral host range, and evolutionary context. Unexceptional disease in bats from novel or co-evolved infections suggests that order-level host life history traits such as flight have inconsistent consequences for antiviral immunity and highlights the need to evaluate the functional properties of putatively unique features of bat immunity in vivo. These results do not exclude the possibility of developing broader-acting or more potent antivirals from bat immune systems nor do they diminish the potential value of mechanistic insights into bat immunity. However, they do not support the premise underlying the idea that bats will be an unusually rich source of future biomedical breakthroughs.
- organism: mouse
- organism: rat
- organism: human
- research focus: host-pathogen & immune response
- approach: statistical model
- Citations
- 3
- FWCI
- 14.99
- Field percentile
- top 3%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence
C. E. Brook, M. Boots, … A. van Leeuwen·bioRxiv·Feb 1, 2020
- Reservoir host immunology and life history shape virulence evolution in zoonotic viruses
C. E. Brook, C. Rozins, … M. Boots·bioRxiv·Oct 6, 2021
- The virome of bats inhabiting Brazilian biomes: knowledge gaps and biases towards zoonotic viruses
G. d. L. Wallau, E. Barbier, … E. Bernard·bioRxiv·Oct 11, 2022
- Individual bat viromes reveal the co-infection, spillover and emergence risk of potential zoonotic viruses
- Reconstructing bat antiviral immunity using epithelial organoids
Max J. Kellner, Vanessa Monteil, … Josef Martin Penninger·Nature ImmunologyPeer-reviewed·May 21, 2025
- Bat pluripotent stem cells reveal unique entanglement between host and viruses
Marion Déjosez, Arturo Marín, … Thomas P. Zwaka·bioRxiv·Sep 23, 2022